NDC 71894-110 - Zolgensma
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71894-110
- Package NDCs from labels
- 71894-110-01
- Manufacturer
- Novartis Innovative Technologies Inc.
- Effective date
- 2026-06-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Zolgensma - Novartis Innovative Technologies Inc. | Novartis Innovative Technologies Inc. | 2026-06-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Electrolyte Plus | KALI MURIATICUM, L-ARGININE, L-CARNITINE, L-LEUCINE, L-ORNITHINE, L-VALINE, MAGNESIA MURIATICA, ASCORBICUM ACIDUM, BORAX, CHROMIUM OXYDATUM, FERRUM MURIATICUM, KALI CARBONICUM, MAGNESIUM GLUCONICUM DIHYDRICUM, NATRUM MURIATICUM, ZINCUM GLUCONICUM, CUPRUM METALLICUM, KALI PHOSPHORICUM, NICCOLUM METALLICUM, SELENIUM METALLICUM, VANADIUM METALLICUM, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, MANGANUM CARBONICUM | Deseret Biologicals, Inc. | e3564733-8b88-4753-9077-9d74004d8ec9 | 2026-08-25 | Warnings | 02F3473H9O 451W47IQ8X |
| Sterile Water | WATER | REMEDYREPACK INC. | 5dd5d148-6e23-41de-bff5-551b2aea9598 | 2026-08-24 | Warnings, Adverse reactions | 059QF0KO0R |
| Aging Eye Formula | CINERARIA MARITIMA, EYE (SUIS), CALCAREA FLUORICA, CAUSTICUM, PHOSPHORUS, SILICEA, ZINCUM METALLICUM, GERMANIUM METALLICUM, NATRUM MURIATICUM | Nutritional Specialties, Inc. | d5b44f79-5299-4b31-ba45-0e511cdbe17c | 2026-08-24 | Warnings | 451W47IQ8X |
| Bio Combination 28 | SCHUESSLER SALTS | LDD Bioscience Private Limited | 597caf33-5107-9dec-e063-6294a90a5fcd | 2026-08-20 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | YYBA CORP | 597f3347-647c-3545-e063-6294a90abab2 | 2026-08-20 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 2e5fe9f4-78e5-4af4-8bf9-9680e5dc5e88 | 2026-08-20 | Warnings, Adverse reactions | 451W47IQ8X |
| Sinusforce-HP | ARSENICUM ALBUM, HEPAR SULPHURIS CALCAREUM, KALI BICHROMICUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SEPIA | BioActive Nutritional, Inc. | 53c96680-210b-4426-8b41-3b9a882848dd | 2026-08-20 | Warnings | 451W47IQ8X |
| CVS Saline | NASAL | CVS PHARMACY | f02c41b0-c78e-41cd-aa4a-2756bbe92087 | 2026-08-19 | Warnings | 451W47IQ8X |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | df18a603-ca12-4b26-83b5-9dd07b6453ab | 2026-08-18 | Warnings, Adverse reactions | 451W47IQ8X |
| inControl alcohol | ISOPROPYL ALCOHOL | H-E-B | 45dfbd7a-0ae1-4146-9527-5483c884e636 | 2026-08-18 | Warnings | 797544 ND2M416302 |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | bbc5b820-4973-11e2-a192-0002a5d5c51b | 2026-08-18 | Warnings, Adverse reactions | 02F3473H9O 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | c29bdfa0-4976-11e2-939b-0002a5d5c51b | 2026-08-18 | Warnings, Adverse reactions | 02F3473H9O 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | 515dcee0-3e34-11e2-a25f-0800200c9a66 | 2026-08-18 | Warnings, Adverse reactions | 02F3473H9O 451W47IQ8X |
| ZYMFENTRA | INFLIXIMAB-DYYB | CELLTRION USA Inc. | 93a193ab-9f96-4da6-aa7c-31212e81879a | 2026-08-18 | Boxed warning, Warnings, Adverse reactions | 797544 |
| 70% Isopropyl Rubbing Alcohol | ISOPROPYL RUBBING ALCOHOL | The Kroger Co. | b127bba1-ce0b-4142-8b7d-f12f062b0938 | 2026-08-17 | Warnings, Adverse reactions | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | The Kroger Co. | cd3f8779-9e57-4b23-a029-7424d4d4ab2a | 2026-08-17 | Warnings, Adverse reactions | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | The Kroger Co. | ca6c7f8a-d41a-4d77-817c-3dbdc40f890e | 2026-08-17 | Warnings, Adverse reactions | ND2M416302 |
| BM BM63 DROPS | CEANOTHUS, KALI ARSEN, KALI MUR, SELENIUM, THALLIUM, WIESBADEN | BM Private Limited | 59006d82-610a-2e08-e063-6394a90af1ed | 2026-08-14 | Warnings | 059QF0KO0R |
| BM BM173 DROPS | ECHINACEA, EUPHRASIA, NATRUM MUR, RHUS TOX, SILICEA, SULPHUR, URTICA UREN | BM Private Limited | 59036ca4-e7bb-bbe7-e063-6394a90a410a | 2026-08-14 | Warnings | 451W47IQ8X |
| Natural Lift Lack of energy - Fatigue | AVENA SATIVA 9C, GELSEMIUM SEMPERVIRENS 9C, PANAX GINSENG 3C, NATRUM MURIATICUM 9C | SEVENE USA | 551194c4-dfd8-c42d-e063-6294a90aecee | 2026-08-13 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.